| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $-0.13717 (Beat by $0.31283) |
| EPS GAAP Actual | $-0.13717 (Beat by $0.31283) |
| Revenue Actual | $0.035049B |
| Revenue Surprise | Beat by $35.049M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.294 |
| EPS GAAP Estimate | $-0.294 |
| Revenue Estimate | $0.0470508B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | 7.81 | 4.27 | 7.35443 | 8.59533 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.38 | -0.12 | 0.035049B | 22.99% | -6.3M |
| FQ1 2025 (Mar 2025) | -0.42 | -0.032 | 0.032632B | 20.5% | -5.61M |
| FQ4 2024 (Dec 2024) | -0.48 | -0.48 | 0.030092B | 18.77% | 30.09M |
| FQ3 2024 (Sep 2024) | -0.54 | -0.54 | 0.028075B | 20.89% | 28.08M |
| FQ2 2024 (Jun 2024) | -0.53 | -0.53 | 0.02699B | 28.14% | 26.99M |
| FQ4 2019 (Dec 2019) | -18.04 | -18.04 | 0.002086B | 100% | 2.09M |
| FQ1 2024 (Mar 2024) | -0.55 | -0.55 | 0.025944B | 33.59% | 25.94M |
| FQ4 2023 (Dec 2023) | -0.0009 | -0.0009 | 0.024444B | 100% | 24.44M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.294
Consensus Revenue Estimates
0.0470508B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.09 | -- | -0.09215027 | -0.08865924 | 1 |
| FQ3 2027 (Sep 2027) | -0.12 | -- | -0.12287 | -0.11821 | 1 |
| FQ2 2027 (Jun 2027) | -0.15 | -- | -0.15358 | -0.14777 | 1 |
| FQ1 2027 (Mar 2027) | -0.17 | -- | -0.17406 | -0.16747 | 1 |
| FQ4 2026 (Oct 2026) | -0.49 | -- | -0.50505 | -0.474 | 1 |
| FQ3 2026 (Jul 2026) | -0.5 | -- | -0.51535 | -0.48367 | 1 |
| FQ2 2026 (Jun 2026) | -0.5 | 24 | -0.54756 | -0.44776 | 0 |
| FQ1 2026 (Mar 2026) | -0.48 | 12.5 | -0.52566 | -0.42985 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.07B | -- | 0.07B | 0.07B | 2 |
| FQ3 2027 (Sep 2027) | 0.06B | -- | 0.06B | 0.07B | 2 |
| FQ2 2027 (Jun 2027) | 0.06B | -- | 0.06B | 0.06B | 2 |
| FQ1 2027 (Mar 2027) | 0.06B | -- | 0.06B | 0.06B | 2 |
| FQ4 2026 (Oct 2026) | 0.06B | -- | 0.05B | 0.06B | 4 |
| FQ3 2026 (Jul 2026) | 0.05B | -- | 0.05B | 0.05B | 4 |
| FQ2 2026 (Jun 2026) | 0.05B | 32.6 | 0.05B | 0.06B | 4 |
| FQ1 2026 (Mar 2026) | 0.05B | 34.74 | 0.05B | 0.05B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.26 | -0.38 | -0.12 | 31.58% |
| FQ1 2025 (Mar 2025) | -0.388 | -0.42 | -0.032 | 7.62% |
| FQ4 2024 (Dec 2024) | -0.48 | -0.48 | 100% | |
| FQ3 2024 (Sep 2024) | -0.54 | -0.54 | 100% | |
| FQ2 2024 (Jun 2024) | -0.53 | -0.53 | 100% | |
| FQ4 2019 (Dec 2019) | -18.04 | -18.04 | 100% | |
| FQ1 2024 (Mar 2024) | -0.55 | -0.55 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0009 | -0.0009 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.04B | $0.04B | $-6.3M | -17.98% |
| FQ1 2025 (Mar 2025) | $0.04B | $0.03B | $-5.61M | -17.21% |
| FQ4 2024 (Dec 2024) | $0B | $0.03B | $30.09M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.03B | $28.08M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.03B | $26.99M | 100% |
| FQ4 2019 (Dec 2019) | $0B | $0B | $2.09M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.03B | $25.94M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.02B | $24.44M | 100% |